2023-505806-41-00招募中2 期
A study of the safety and efficacy of MB-dNPM-1-TCR.1 in patients with relapsed or refractory AML.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 32
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Desk
Scientific
Miltenyi Biomedicine GmbH
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Study on safety and efficacy of NMS-01940153E in adult patients with unresectable liver tumor previously treated with systemic therapy.EUCTR2020-001002-26-ITERVIANO MEDICAL SCIENCES SR60
未知
2 期
Phase 2 Study of MR13A9.JPRN-jRCT2080223210Maruishi Pharmaceutical Co., Ltd.100
招募中
不适用
Safety and performance confirmation study with dMD-003jRCT2032240323Mochida Pharmaceutical Co., Ltd.15
招募中
2 期
Comparative Study of Efficacy and Safety of M-Bone (Biphasic Calcium Phosphate with Hydroxyapatite:Beta-tricalcium Phosphate of 70:30) versus Reference Commercial Product for Socket PreservatioTooth socket preservationBiphasic Calcium PhosphateHydroxyapatite and Beta-tricalcium PhosphateTCTR20200402006Assistive Technology and Medical Devices Research Center (A-MED)48
招募中
不适用
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults over 60 Years of AgejRCT2031220274ModernaTX, Inc.700